TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Janssons Immunbiologiska AB JIBA
Closing information (x1000 NOK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
6,311
|
5,846
|
6,388 |
| Financial expenses |
3
|
7
|
7 |
| Earnings before taxes |
1,212
|
1,134
|
2,004 |
| EBITDA |
1,211
|
1,140
|
2,016 |
| Total assets |
3,326
|
3,114
|
2,516 |
| Current assets |
3,326
|
3,114
|
2,516 |
| Current liabilities |
566
|
569
|
804 |
| Equity capital |
2,759
|
2,545
|
1,707 |
| - share capital |
101
|
95
|
98 |
| Employees (average) |
2
|
2
|
5 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
83.0%
|
81.7%
|
67.8% |
| Turnover per employee |
3,156
|
2,923
|
1,278 |
| Profit as a percentage of turnover |
19.2%
|
19.4%
|
31.4% |
| Return on assets (ROA) |
36.5%
|
36.6%
|
79.9% |
| Current ratio |
587.6%
|
547.3%
|
312.9% |
| Return on equity (ROE) |
43.9%
|
44.6%
|
117.4% |
| Change turnover |
51
|
-350
|
-547 |
| Change turnover % |
1%
|
-6%
|
-8% |
| Chg. No. of employees |
0
|
-3
|
0 |
| Chg. No. of employees % |
0%
|
-60%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.